Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C22H21FN6O4S and a molecular weight of approximately 484.5 g/mol. It is not approved for clinical use in any jurisdiction and has no known marketed indications or brand names. The structure features a pyrrolopyrimidine core linked to substituted benzamide and methoxyphenyl groups, including a methylsulfonyl moiety. There is no published information on its mechanism of action, biological targets, or therapeutic applications in humans. It appears to be an experimental molecule cataloged in chemical databases such as DrugBank (DB07845), PubChem (CID: 25113171), and ChemSpider (ID: 25061137)[1][3][4]. No clinical trials or development programs are currently associated with this compound.
- Other names
- 2-fluoro-6-{[2-(2-methoxy-4-(methylsulfonyl)methyl)phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-y]amino}benzamide68814–04–01123162–87–7DTXSID60920497DTXSID-60920497DTXSID 60920497
02
Targets
PTK (Protein-Tyrosine Kinase)
Beyond the preview
Go deeper on 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide.